The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
Fast Track designation granted by U.S. FDA for evaluation of ETX-19477 in patients with BRCA-mutated, platinum-resistant ...
Hosted on MSN
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations, analysis suggests
Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched ...
Soap Hub on MSN
BTG The Rinse January 9: Dani And Nicole Learn Their Fate
In the January 9 episode of Beyond the Gates, Anita began her chemotherapy, while Nicole and Dani learned if they carried the ...
Kara Tointon has spoken out after undergoing a double mastectomy following a genetic test. The former EastEnders star, who ...
While that might sound a good thing, the truth is a bit more complicated. For starters, not everyone needs to get tested, as these gene mutations are still fairly rare, affecting only about 1 in 400 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback